Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Index by author

August 01, 1990; Volume 38,Issue 2
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Aicher, L D

    1. You have access
      Stimulation of porphyrinogen oxidation by mercuric ion. I. Evidence of free radical formation in the presence of thiols and hydrogen peroxide.
      J S Woods, C A Calas, L D Aicher, B H Robinson and C Mailer
      Molecular Pharmacology August 1990, 38 (2) 253-260;
    2. You have access
      Stimulation of porphyrinogen oxidation by mercuric ion. II. Promotion of oxidation from the interaction of mercuric ion, glutathione, and mitochondria-generated hydrogen peroxide.
      J S Woods, C A Calas and L D Aicher
      Molecular Pharmacology August 1990, 38 (2) 261-266;

B

  1. Baker, R M

    1. You have access
      Characterization of auromomycin-resistant hamster cell mutants that display a multidrug resistance phenotype.
      F J Rauscher, T A Beerman and R M Baker
      Molecular Pharmacology August 1990, 38 (2) 198-206;
  2. Barrett, R W

    1. You have access
      Biochemical characterization of the cholecystokinin receptor on CHP212 human neuroblastoma cells.
      U G Klueppelberg, X Molero, R W Barrett and L J Miller
      Molecular Pharmacology August 1990, 38 (2) 159-163;
  3. Barrington, W W

    1. You have access
      Glycoprotein nature of the A2-adenosine receptor binding subunit.
      W W Barrington, K A Jacobson and G L Stiles
      Molecular Pharmacology August 1990, 38 (2) 177-183;
  4. Bauce, L

    1. You have access
      Kainate receptors coupled to the evoked release of [3H]-gamma-aminobutyric acid from striatal neurons in primary culture: potentiation by lithium ions.
      S Weiss, D E Kemp, L Bauce and F W Tse
      Molecular Pharmacology August 1990, 38 (2) 229-236;
  5. Beerman, T A

    1. You have access
      Characterization of auromomycin-resistant hamster cell mutants that display a multidrug resistance phenotype.
      F J Rauscher, T A Beerman and R M Baker
      Molecular Pharmacology August 1990, 38 (2) 198-206;
  6. Benishin, C G

    1. You have access
      Potassium channel blockade by the B subunit of beta-bungarotoxin.
      C G Benishin
      Molecular Pharmacology August 1990, 38 (2) 164-169;
  7. Boulanger, C

    1. You have access
      Internalization of endothelin by cultured human vascular smooth muscle cells: characterization and physiological significance.
      T J Resink, T Scott-Burden, C Boulanger, E Weber and F R Bühler
      Molecular Pharmacology August 1990, 38 (2) 244-252;
  8. Brian, W R

    1. You have access
      Studies on the expression and metabolic capabilities of human liver cytochrome P450IIIA5 (HLp3).
      S A Wrighton, W R Brian, M A Sari, M Iwasaki, F P Guengerich, J L Raucy, D T Molowa and M Vandenbranden
      Molecular Pharmacology August 1990, 38 (2) 207-213;
  9. Bühler, F R

    1. You have access
      Internalization of endothelin by cultured human vascular smooth muscle cells: characterization and physiological significance.
      T J Resink, T Scott-Burden, C Boulanger, E Weber and F R Bühler
      Molecular Pharmacology August 1990, 38 (2) 244-252;

C

  1. Calas, C A

    1. You have access
      Stimulation of porphyrinogen oxidation by mercuric ion. I. Evidence of free radical formation in the presence of thiols and hydrogen peroxide.
      J S Woods, C A Calas, L D Aicher, B H Robinson and C Mailer
      Molecular Pharmacology August 1990, 38 (2) 253-260;
    2. You have access
      Stimulation of porphyrinogen oxidation by mercuric ion. II. Promotion of oxidation from the interaction of mercuric ion, glutathione, and mitochondria-generated hydrogen peroxide.
      J S Woods, C A Calas and L D Aicher
      Molecular Pharmacology August 1990, 38 (2) 261-266;
  2. Campbell, M D

    1. You have access
      Cyclic AMP inhibits inositol polyphosphate production and calcium mobilization in neuroblastoma X glioma NG108-15 cells.
      M D Campbell, S Subramaniam, M I Kotlikoff, J R Williamson and S J Fluharty
      Molecular Pharmacology August 1990, 38 (2) 282-288;
  3. Camus, J

    1. You have access
      Binding of selective antagonists to four muscarinic receptors (M1 to M4) in rat forebrain.
      M Waelbroeck, M Tastenoy, J Camus and J Christophe
      Molecular Pharmacology August 1990, 38 (2) 267-273;
  4. Christophe, J

    1. You have access
      Binding of selective antagonists to four muscarinic receptors (M1 to M4) in rat forebrain.
      M Waelbroeck, M Tastenoy, J Camus and J Christophe
      Molecular Pharmacology August 1990, 38 (2) 267-273;

E

  1. Eriksson, S

    1. You have access
      2',3'-Dideoxycytidine toxicity in cultured human CEM T lymphoblasts: effects of combination with 3'-azido-3'-deoxythymidine and thymidine.
      Y Törnevik and S Eriksson
      Molecular Pharmacology August 1990, 38 (2) 237-243;

F

  1. Fluharty, S J

    1. You have access
      Cyclic AMP inhibits inositol polyphosphate production and calcium mobilization in neuroblastoma X glioma NG108-15 cells.
      M D Campbell, S Subramaniam, M I Kotlikoff, J R Williamson and S J Fluharty
      Molecular Pharmacology August 1990, 38 (2) 282-288;

G

  1. Gerhardt, M A

    1. You have access
      p-[125I]iodoclonidine is a partial agonist at the alpha 2-adrenergic receptor.
      M A Gerhardt, S M Wade and R R Neubig
      Molecular Pharmacology August 1990, 38 (2) 214-221;
  2. Guengerich, F P

    1. You have access
      Studies on the expression and metabolic capabilities of human liver cytochrome P450IIIA5 (HLp3).
      S A Wrighton, W R Brian, M A Sari, M Iwasaki, F P Guengerich, J L Raucy, D T Molowa and M Vandenbranden
      Molecular Pharmacology August 1990, 38 (2) 207-213;
  3. Gustafsson, J A

    1. You have access
      Growth hormone regulation of the cytochrome P-450IIC subfamily in the rat: inductive, repressive, and transcriptional effects on P-450f (IIC7) and P-450PB1 (IIC6) gene expression.
      S Westin, A Ström, J A Gustafsson and P G Zaphiropoulos
      Molecular Pharmacology August 1990, 38 (2) 192-197;

I

  1. Imai, S

    1. You have access
      Effects of sulfhydryl-modifying reagents, 3-nitro-2-pyridinesulfenyl compounds, on the coupling between inhibitory receptors and GTP-binding proteins Gi/Go in rat brain membranes.
      Y Kitamura, S Imai, R Matsueda and Y Nomura
      Molecular Pharmacology August 1990, 38 (2) 184-191;
  2. Iwasaki, M

    1. You have access
      Studies on the expression and metabolic capabilities of human liver cytochrome P450IIIA5 (HLp3).
      S A Wrighton, W R Brian, M A Sari, M Iwasaki, F P Guengerich, J L Raucy, D T Molowa and M Vandenbranden
      Molecular Pharmacology August 1990, 38 (2) 207-213;

J

  1. Jacobson, K A

    1. You have access
      Glycoprotein nature of the A2-adenosine receptor binding subunit.
      W W Barrington, K A Jacobson and G L Stiles
      Molecular Pharmacology August 1990, 38 (2) 177-183;
  2. Johnson, B G

    1. You have access
      Stereoselectivity and mode of inhibition of phosphoinositide-coupled excitatory amino acid receptors by 2-amino-3-phosphonopropionic acid.
      D D Schoepp, B G Johnson, E C Smith and L A McQuaid
      Molecular Pharmacology August 1990, 38 (2) 222-228;

K

  1. Kemp, D E

    1. You have access
      Kainate receptors coupled to the evoked release of [3H]-gamma-aminobutyric acid from striatal neurons in primary culture: potentiation by lithium ions.
      S Weiss, D E Kemp, L Bauce and F W Tse
      Molecular Pharmacology August 1990, 38 (2) 229-236;
  2. Kitamura, Y

    1. You have access
      Effects of sulfhydryl-modifying reagents, 3-nitro-2-pyridinesulfenyl compounds, on the coupling between inhibitory receptors and GTP-binding proteins Gi/Go in rat brain membranes.
      Y Kitamura, S Imai, R Matsueda and Y Nomura
      Molecular Pharmacology August 1990, 38 (2) 184-191;
  3. Klueppelberg, U G

    1. You have access
      Biochemical characterization of the cholecystokinin receptor on CHP212 human neuroblastoma cells.
      U G Klueppelberg, X Molero, R W Barrett and L J Miller
      Molecular Pharmacology August 1990, 38 (2) 159-163;
  4. Kotlikoff, M I

    1. You have access
      Cyclic AMP inhibits inositol polyphosphate production and calcium mobilization in neuroblastoma X glioma NG108-15 cells.
      M D Campbell, S Subramaniam, M I Kotlikoff, J R Williamson and S J Fluharty
      Molecular Pharmacology August 1990, 38 (2) 282-288;

L

  1. Linden, J

    1. You have access
      Interaction of purified bovine brain A1-adenosine receptors with guanine nucleotide-binding proteins of human platelet membranes following reconstitution.
      R Munshi and J Linden
      Molecular Pharmacology August 1990, 38 (2) 170-176;

M

  1. Mailer, C

    1. You have access
      Stimulation of porphyrinogen oxidation by mercuric ion. I. Evidence of free radical formation in the presence of thiols and hydrogen peroxide.
      J S Woods, C A Calas, L D Aicher, B H Robinson and C Mailer
      Molecular Pharmacology August 1990, 38 (2) 253-260;
  2. Matsueda, R

    1. You have access
      Effects of sulfhydryl-modifying reagents, 3-nitro-2-pyridinesulfenyl compounds, on the coupling between inhibitory receptors and GTP-binding proteins Gi/Go in rat brain membranes.
      Y Kitamura, S Imai, R Matsueda and Y Nomura
      Molecular Pharmacology August 1990, 38 (2) 184-191;
  3. McQuaid, L A

    1. You have access
      Stereoselectivity and mode of inhibition of phosphoinositide-coupled excitatory amino acid receptors by 2-amino-3-phosphonopropionic acid.
      D D Schoepp, B G Johnson, E C Smith and L A McQuaid
      Molecular Pharmacology August 1990, 38 (2) 222-228;
  4. Miller, L J

    1. You have access
      Biochemical characterization of the cholecystokinin receptor on CHP212 human neuroblastoma cells.
      U G Klueppelberg, X Molero, R W Barrett and L J Miller
      Molecular Pharmacology August 1990, 38 (2) 159-163;
  5. Minneman, K P

    1. You have access
      Pertussis toxin inhibits norepinephrine-stimulated inositol phosphate formation in primary brain cell cultures.
      K M Wilson and K P Minneman
      Molecular Pharmacology August 1990, 38 (2) 274-281;
  6. Molero, X

    1. You have access
      Biochemical characterization of the cholecystokinin receptor on CHP212 human neuroblastoma cells.
      U G Klueppelberg, X Molero, R W Barrett and L J Miller
      Molecular Pharmacology August 1990, 38 (2) 159-163;
  7. Molowa, D T

    1. You have access
      Studies on the expression and metabolic capabilities of human liver cytochrome P450IIIA5 (HLp3).
      S A Wrighton, W R Brian, M A Sari, M Iwasaki, F P Guengerich, J L Raucy, D T Molowa and M Vandenbranden
      Molecular Pharmacology August 1990, 38 (2) 207-213;
  8. Munshi, R

    1. You have access
      Interaction of purified bovine brain A1-adenosine receptors with guanine nucleotide-binding proteins of human platelet membranes following reconstitution.
      R Munshi and J Linden
      Molecular Pharmacology August 1990, 38 (2) 170-176;

N

  1. Neubig, R R

    1. You have access
      p-[125I]iodoclonidine is a partial agonist at the alpha 2-adrenergic receptor.
      M A Gerhardt, S M Wade and R R Neubig
      Molecular Pharmacology August 1990, 38 (2) 214-221;
  2. Nomura, Y

    1. You have access
      Effects of sulfhydryl-modifying reagents, 3-nitro-2-pyridinesulfenyl compounds, on the coupling between inhibitory receptors and GTP-binding proteins Gi/Go in rat brain membranes.
      Y Kitamura, S Imai, R Matsueda and Y Nomura
      Molecular Pharmacology August 1990, 38 (2) 184-191;

R

  1. Raucy, J L

    1. You have access
      Studies on the expression and metabolic capabilities of human liver cytochrome P450IIIA5 (HLp3).
      S A Wrighton, W R Brian, M A Sari, M Iwasaki, F P Guengerich, J L Raucy, D T Molowa and M Vandenbranden
      Molecular Pharmacology August 1990, 38 (2) 207-213;
  2. Rauscher, F J

    1. You have access
      Characterization of auromomycin-resistant hamster cell mutants that display a multidrug resistance phenotype.
      F J Rauscher, T A Beerman and R M Baker
      Molecular Pharmacology August 1990, 38 (2) 198-206;
  3. Resink, T J

    1. You have access
      Internalization of endothelin by cultured human vascular smooth muscle cells: characterization and physiological significance.
      T J Resink, T Scott-Burden, C Boulanger, E Weber and F R Bühler
      Molecular Pharmacology August 1990, 38 (2) 244-252;
  4. Robinson, B H

    1. You have access
      Stimulation of porphyrinogen oxidation by mercuric ion. I. Evidence of free radical formation in the presence of thiols and hydrogen peroxide.
      J S Woods, C A Calas, L D Aicher, B H Robinson and C Mailer
      Molecular Pharmacology August 1990, 38 (2) 253-260;

S

  1. Sari, M A

    1. You have access
      Studies on the expression and metabolic capabilities of human liver cytochrome P450IIIA5 (HLp3).
      S A Wrighton, W R Brian, M A Sari, M Iwasaki, F P Guengerich, J L Raucy, D T Molowa and M Vandenbranden
      Molecular Pharmacology August 1990, 38 (2) 207-213;
  2. Schoepp, D D

    1. You have access
      Stereoselectivity and mode of inhibition of phosphoinositide-coupled excitatory amino acid receptors by 2-amino-3-phosphonopropionic acid.
      D D Schoepp, B G Johnson, E C Smith and L A McQuaid
      Molecular Pharmacology August 1990, 38 (2) 222-228;
  3. Scott-Burden, T

    1. You have access
      Internalization of endothelin by cultured human vascular smooth muscle cells: characterization and physiological significance.
      T J Resink, T Scott-Burden, C Boulanger, E Weber and F R Bühler
      Molecular Pharmacology August 1990, 38 (2) 244-252;
  4. Smith, E C

    1. You have access
      Stereoselectivity and mode of inhibition of phosphoinositide-coupled excitatory amino acid receptors by 2-amino-3-phosphonopropionic acid.
      D D Schoepp, B G Johnson, E C Smith and L A McQuaid
      Molecular Pharmacology August 1990, 38 (2) 222-228;
  5. Stiles, G L

    1. You have access
      Glycoprotein nature of the A2-adenosine receptor binding subunit.
      W W Barrington, K A Jacobson and G L Stiles
      Molecular Pharmacology August 1990, 38 (2) 177-183;
  6. Ström, A

    1. You have access
      Growth hormone regulation of the cytochrome P-450IIC subfamily in the rat: inductive, repressive, and transcriptional effects on P-450f (IIC7) and P-450PB1 (IIC6) gene expression.
      S Westin, A Ström, J A Gustafsson and P G Zaphiropoulos
      Molecular Pharmacology August 1990, 38 (2) 192-197;
  7. Subramaniam, S

    1. You have access
      Cyclic AMP inhibits inositol polyphosphate production and calcium mobilization in neuroblastoma X glioma NG108-15 cells.
      M D Campbell, S Subramaniam, M I Kotlikoff, J R Williamson and S J Fluharty
      Molecular Pharmacology August 1990, 38 (2) 282-288;

T

  1. Tastenoy, M

    1. You have access
      Binding of selective antagonists to four muscarinic receptors (M1 to M4) in rat forebrain.
      M Waelbroeck, M Tastenoy, J Camus and J Christophe
      Molecular Pharmacology August 1990, 38 (2) 267-273;
  2. Törnevik, Y

    1. You have access
      2',3'-Dideoxycytidine toxicity in cultured human CEM T lymphoblasts: effects of combination with 3'-azido-3'-deoxythymidine and thymidine.
      Y Törnevik and S Eriksson
      Molecular Pharmacology August 1990, 38 (2) 237-243;
  3. Tse, F W

    1. You have access
      Kainate receptors coupled to the evoked release of [3H]-gamma-aminobutyric acid from striatal neurons in primary culture: potentiation by lithium ions.
      S Weiss, D E Kemp, L Bauce and F W Tse
      Molecular Pharmacology August 1990, 38 (2) 229-236;

V

  1. Vandenbranden, M

    1. You have access
      Studies on the expression and metabolic capabilities of human liver cytochrome P450IIIA5 (HLp3).
      S A Wrighton, W R Brian, M A Sari, M Iwasaki, F P Guengerich, J L Raucy, D T Molowa and M Vandenbranden
      Molecular Pharmacology August 1990, 38 (2) 207-213;

W

  1. Wade, S M

    1. You have access
      p-[125I]iodoclonidine is a partial agonist at the alpha 2-adrenergic receptor.
      M A Gerhardt, S M Wade and R R Neubig
      Molecular Pharmacology August 1990, 38 (2) 214-221;
  2. Waelbroeck, M

    1. You have access
      Binding of selective antagonists to four muscarinic receptors (M1 to M4) in rat forebrain.
      M Waelbroeck, M Tastenoy, J Camus and J Christophe
      Molecular Pharmacology August 1990, 38 (2) 267-273;
  3. Weber, E

    1. You have access
      Internalization of endothelin by cultured human vascular smooth muscle cells: characterization and physiological significance.
      T J Resink, T Scott-Burden, C Boulanger, E Weber and F R Bühler
      Molecular Pharmacology August 1990, 38 (2) 244-252;
  4. Weiss, S

    1. You have access
      Kainate receptors coupled to the evoked release of [3H]-gamma-aminobutyric acid from striatal neurons in primary culture: potentiation by lithium ions.
      S Weiss, D E Kemp, L Bauce and F W Tse
      Molecular Pharmacology August 1990, 38 (2) 229-236;
  5. Westin, S

    1. You have access
      Growth hormone regulation of the cytochrome P-450IIC subfamily in the rat: inductive, repressive, and transcriptional effects on P-450f (IIC7) and P-450PB1 (IIC6) gene expression.
      S Westin, A Ström, J A Gustafsson and P G Zaphiropoulos
      Molecular Pharmacology August 1990, 38 (2) 192-197;
  6. Williamson, J R

    1. You have access
      Cyclic AMP inhibits inositol polyphosphate production and calcium mobilization in neuroblastoma X glioma NG108-15 cells.
      M D Campbell, S Subramaniam, M I Kotlikoff, J R Williamson and S J Fluharty
      Molecular Pharmacology August 1990, 38 (2) 282-288;
  7. Wilson, K M

    1. You have access
      Pertussis toxin inhibits norepinephrine-stimulated inositol phosphate formation in primary brain cell cultures.
      K M Wilson and K P Minneman
      Molecular Pharmacology August 1990, 38 (2) 274-281;
  8. Woods, J S

    1. You have access
      Stimulation of porphyrinogen oxidation by mercuric ion. I. Evidence of free radical formation in the presence of thiols and hydrogen peroxide.
      J S Woods, C A Calas, L D Aicher, B H Robinson and C Mailer
      Molecular Pharmacology August 1990, 38 (2) 253-260;
    2. You have access
      Stimulation of porphyrinogen oxidation by mercuric ion. II. Promotion of oxidation from the interaction of mercuric ion, glutathione, and mitochondria-generated hydrogen peroxide.
      J S Woods, C A Calas and L D Aicher
      Molecular Pharmacology August 1990, 38 (2) 261-266;
  9. Wrighton, S A

    1. You have access
      Studies on the expression and metabolic capabilities of human liver cytochrome P450IIIA5 (HLp3).
      S A Wrighton, W R Brian, M A Sari, M Iwasaki, F P Guengerich, J L Raucy, D T Molowa and M Vandenbranden
      Molecular Pharmacology August 1990, 38 (2) 207-213;

Z

  1. Zaphiropoulos, P G

    1. You have access
      Growth hormone regulation of the cytochrome P-450IIC subfamily in the rat: inductive, repressive, and transcriptional effects on P-450f (IIC7) and P-450PB1 (IIC6) gene expression.
      S Westin, A Ström, J A Gustafsson and P G Zaphiropoulos
      Molecular Pharmacology August 1990, 38 (2) 192-197;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 38, Issue 2
1 Aug 1990
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Read
Loading
  • Proteomic Analysis of GPCR Cell Biology
  • Phosphoproteomic Analysis of cAMP-Dependent Pathways
  • Phosphoproteomic Identification of Signaling Pathways
  • How Many G Protein-Coupled Receptors are Drug Targets?
  • Characterization of GRD and LCCH3 from Human Louse
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics